These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 22155910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
    Corbett AH, Hosseinipour MC, Nyirenda J, Kanyama C, Rezk NL, Mkupani P, Sichali D, Tien H, Kashuba AD, Mwansambo C, Weigel R, Kazembe P.
    Antivir Ther; 2010; 15(1):83-90. PubMed ID: 20167994
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
    Chokephaibulkit K, Plipat N, Cressey TR, Frederix K, Phongsamart W, Capparelli E, Kolladarungkri T, Vanprapar N.
    AIDS; 2005 Sep 23; 19(14):1495-9. PubMed ID: 16135903
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
    Crémieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F, AZl10002 Study Group.
    Pharmacotherapy; 2001 Apr 23; 21(4):424-30. PubMed ID: 11310515
    [Abstract] [Full Text] [Related]

  • 6. Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.
    Poerksen G, Pollock L, Moons P, Chesshyre E, Burger D, Khoo S, Molyneux E.
    Antivir Ther; 2010 Apr 23; 15(3):343-50. PubMed ID: 20516554
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Ferrier A, Chintu C, Walker AS, Gibb DM, Burger DM.
    AIDS; 2012 Sep 10; 26(14):1795-800. PubMed ID: 22739394
    [Abstract] [Full Text] [Related]

  • 8. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
    Kayitare E, Vervaet C, Ntawukulilyayo JD, Seminega B, Bortel V, Remon JP.
    Int J Pharm; 2009 Mar 31; 370(1-2):41-6. PubMed ID: 19059324
    [Abstract] [Full Text] [Related]

  • 9. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Rao Thudi N, Koundinya Tippabhotla S, Khuroo A, Marwah A, Kumar Shrivastav V, Tandon M, Raghuvanshi R, Biswal S.
    Clin Ther; 2007 Dec 31; 29(12):2677-84. PubMed ID: 18201583
    [Abstract] [Full Text] [Related]

  • 10. Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations.
    Bouazza N, Foissac F, Fauchet F, Burger D, Kiechel JR, Treluyer JM, Capparelli EV, Lallemant M, Urien S.
    Antivir Ther; 2015 Dec 31; 20(2):225-33. PubMed ID: 25279808
    [Abstract] [Full Text] [Related]

  • 11. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
    L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM.
    AIDS; 2008 Mar 12; 22(5):557-65. PubMed ID: 18316996
    [Abstract] [Full Text] [Related]

  • 12. Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption.
    Yuen GJ, Lou Y, Thompson NF, Otto VR, Allsup TL, Mahony WB, Hutman HW.
    J Clin Pharmacol; 2001 Mar 12; 41(3):277-88. PubMed ID: 11269568
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092.
    Owor M, Tierney C, Ziemba L, Browning R, Moye J, Graham B, Reding C, Costello D, Norman J, Wiesner L, Hughes E, Whalen ME, Purdue L, Mmbaga BT, Kamthunzi P, Kawalazira R, Nathoo K, Bradford S, Coletti A, Aweeka F, Musoke P.
    Pediatr Infect Dis J; 2021 May 01; 40(5):446-452. PubMed ID: 33464021
    [Abstract] [Full Text] [Related]

  • 14. A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in India.
    Vezina HE, Henry K, Ravindran GD, Kurpad AV, Raj TD, Fox K, Weller D, Brundage RC, Cavert W, Balfour HH.
    J Acquir Immune Defic Syndr; 2006 Feb 01; 41(2):131-6. PubMed ID: 16394842
    [Abstract] [Full Text] [Related]

  • 15. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
    Ellis JC, L'homme RF, Ewings FM, Mulenga V, Bell F, Chileshe R, Molyneux E, Abernethy J, van Oosterhout JJ, Chintu C, Walker AS, Gibb DM, Burger DM.
    Antivir Ther; 2007 Feb 01; 12(2):253-60. PubMed ID: 17503667
    [Abstract] [Full Text] [Related]

  • 16. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
    Narang VS, Lulla A, Malhotra G, Purandare S.
    J Clin Pharmacol; 2005 Mar 01; 45(3):265-74. PubMed ID: 15703362
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India.
    Swaminathan S, Ramachandran G, Agibothu Kupparam HK, Mahalingam V, Soundararajan L, Perumal Kannabiran B, Navaneethapandian PG, Shah I, Karunaianandham R, Sikhamani R.
    J Antimicrob Chemother; 2011 Jun 01; 66(6):1354-9. PubMed ID: 21393201
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
    Marier JF, Dimarco M, Guilbaud R, Dodard C, Morelli G, Tippabhotla SK, Singla AK, Thudi NR, Monif T.
    J Clin Pharmacol; 2007 Nov 01; 47(11):1381-9. PubMed ID: 17962426
    [Abstract] [Full Text] [Related]

  • 19. Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
    Burger D, Ewings F, Kabamba D, L'homme R, Mulenga V, Kankasa C, Thomason M, Gibb DM, Chintu C, Walker AS.
    Ther Drug Monit; 2010 Jun 01; 32(3):369-72. PubMed ID: 20386361
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.